My watch list  

67 Current news of Sartorius


You can refine your search further. Select from the filter options on the left to narrow down your results.

Sartorius first-quarter earnings substantially improved over the year-earlier quarter


The positive earnings development last reported by the Sartorius Group continued in the first quarter of 2004. Earnings before interest, taxes, depreciation and amortization, EBITDA, rose to EUR9.6 million from EUR2.6 million reported a year earlier. At EUR4.1 million, earnings before interest ...


Sartorius Reviews Performance during Fiscal 2003

Consolidation Drive Takes Effect; Ambitious Targets for 2004


In its consolidation drive, the Sartorius Group achieved striking success, and is striving to considerably increase sales revenue and double its operating earnings (EBIT) in the current year. Spokesman of the Executive Board and Group CEO Dr. Joachim Kreuzburg announced this at the annual press ...


Sartorius presents the preliminary figures for fiscal 2003


The Sartorius Group increased its earnings before interest and taxes (EBIT) in fiscal 2003 by 8.6% to 14.7 million euros (previous year: 13.5 million). EBITDA (earnings before interest, taxes, depreciation and amortization) amounts to 37.7 million euros and rose by 3.9% over the year-earlier ...


Sartorius AG's Results for the First Half of 2003


In the first half of 2003, sales revenue of the Sartorius Group fell 6.7% to 217.0 million euros from 232.6 million euros a year earlier, whereas sales revenue adjusted for the impact of foreign exchange rates at 232.9 million euros reached the previous year's level. The Biotechnology Division ...


Sartorius and Alfa Laval sign alliance agreement for innovation in beer filtration


The German-based Sartorius Group has signed an alliance agreement with Alfa Laval. The agreement creates a strong global position for the two companies within the beer filtration sector and provides for further development of a crossflow filtration system for beer, which is an innovative ...


The Sartorius Group Continues to Grow Substantially in the First Half


* The Biotechnology Division grows by 19% * The Mechatronics Division is down 5% * Non-recurring expenses for adapting capacity levels in the Mechatronics Division have a negative impact on earnings * Positive full-year earnings expectations remain unchanged * Restructuring of GWT ...


Sartorius Relocates the Head Office of Its Biotechnology Subsidiary Vivascience to the Medical Park in Hanover, Germany


Sartorius AG’s biotechnology subsidiary, Vivascience Limited, will be included in Vivascience AG so that the headquarters of this subsidiary is, in fact, being relocated from Lincoln, England to Hanover, Germany. This decision marks Sartorius’ commitment to Lower Saxony as a viable business ...


Page 7 From 7
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE